Alternative approaches to IP regulation
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
Line 8: | Line 8: | ||
Brewster et al (2005) [[http://www.biodevelopments.org/innovation/ist3.pdf Innovation Strategy Today]] | Brewster et al (2005) [[http://www.biodevelopments.org/innovation/ist3.pdf Innovation Strategy Today]] | ||
+ | |||
+ | ICRISAT Policy on IPRs [[http://www.icrisat.org/ip_management/policy.htm IP management]] | ||
+ | |||
+ | Possible role for patent pooling in managing SARS [[http://www.who.int/bulletin/volumes/83/9/707.pdf Patent Pooling]] | ||
+ | |||
+ | Patent pools [[http://www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf Patent Pools]] | ||
+ | |||
+ | Anti-commons in biomedical research [[http://0-find.galegroup.com.alpha2.latrobe.edu.au/itx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20606179&source=gale&srcprod=EAIM&userGroupName=latrobe&version=1.0 Anticommons]] | ||
Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] | Return to [[Intellectual Property and Pharmaceuticals | IP Resources page]] |
Revision as of 12:07, 9 July 2007
Australian Research Council, AVCC, NHMRC, DETYA, etc etc (2001). National Principles of Intellectual Property Management of Publicly Funded Research [web reference]
Chaifetz, S., et al., Closing the access gap for health innovations: an open licensing proposal for universities. 2007. Globalisation and Health 3:1, p. 1. [web link]
Universities Allied for Essential Medicines [web link]. Statement of Principles [Principles]
Report of WHO Commission on Intellectual Property Rights, Innovation and Public Health [Web link]
Brewster et al (2005) [Innovation Strategy Today]
ICRISAT Policy on IPRs [IP management]
Possible role for patent pooling in managing SARS [Patent Pooling]
Patent pools [Patent Pools]
Anti-commons in biomedical research [Anticommons]
Return to IP Resources page